The Cancer Research Collaboration and Breastlink New York Partner With Diabetes Prevention Program Provider Blue Mesa Health

The Cancer Research Collaboration (CRC), a non-profit organization dedicated to expanding the availability of cutting-edge cancer research, and Breastlink New York, a leader in breast care that provides complete and total care to all of its patients (from initial screening to the successful completion of treatment), which is a division of RadNet, Inc. (Nasdaq:RDNT), a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, are proud to work in conjunction with Blue Mesa Health’s Transform program.

Blue Mesa Health Inc. Achieves 'Preliminary' Recognition Status From CDC for Diabetes Prevention Program Transform

The Centers for Disease Control and Prevention (CDC) provides recognition and validation of high-quality preventive behavioral health interventions intended for prediabetic Americans via the Diabetes Prevention Recognition Program (DPRP). Blue Mesa Health achieves this status under the recently released 2018 DPRP standards.

Blue Mesa Health joins Nimbus Synergies Inc. Investment Program

Since our inception, Blue Mesa Health has been committed to helping give people the tools and support they need to live chronic-disease free in the United States, Canada, UK and globally. We are proud to be pioneering digital therapeutics and diabetes prevention in Canada and proud to partner with Canadian investment firm Nimbus Synergies Inc. to support our growth: